Laboratoires üma develops products targeting the physiological changes associated with perimenopause, menopause, and post-menopause.
üma Laboratories has raised $4.6M in total funding. The most recent round was Seed. The last funding was announced in September 2026.
üma Laboratories's investors include Kima Ventures, The Moon Venture, DealClub.
üma Laboratories is headquartered in Lyon, France.
Laboratoires üma develops products targeting the physiological changes associated with perimenopause, menopause, and post-menopause.
üma Laboratories is at the Seed stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"üma Laboratories — Funding & Investors." VCBacked, September 18, 2026, https://www.vcbacked.co/company/ma-laboratories. Accessed October 1, 2026.
VCBacked. (2026). üma Laboratories — Funding & Investors. Retrieved October 1, 2026, from https://www.vcbacked.co/company/ma-laboratories
{{cite web |title=üma Laboratories — Funding & Investors |url=https://www.vcbacked.co/company/ma-laboratories |website=VCBacked |access-date=October 1, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated